Cryoport Inc
NASDAQ:CYRX
Cryoport Inc
NASDAQ:CYRX
Price:
17.16 USD
2.08%
Market Closed
Updated:
May 4, 2024
P/OCF
Price to OCF
Price to OCF
-1 110.1
Current
-114.8
Median
15.5
Industry
Lower
than median
Lower
than industry value
Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.
P/OCF
=-1 110.1
Market Cap
/
840.3m
Operating Cash Flow
-757k
All Countries
| Market Cap | P/OCF | ||||
|---|---|---|---|---|---|
| US |
|
Cryoport Inc
NASDAQ:CYRX
|
840.3m USD | -1 110.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
183.5B USD | 25.3 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
135.1B USD | 79.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
124.8B USD | 36 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
108.5B USD | 16.8 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.2B USD | 42.4 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.7B USD | 19.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
57.9B EUR | 24.5 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.6B USD | 57.6 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
50.9B USD | 63.4 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 28 |
P/OCF Forward Multiples
Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A
You don't have any saved screeners yet
